Many studies have shown that a high level of LLT1 expression can significantly restrain NK cells and enhance tumour immune escape, as knockdown of LLT1 enhances NK cell-mediated lysis of tumour tissues [38–40]. The gene discussed is CLEC2D; the disease is neoplasm.